Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vericel Corporation - Common Stock
(NQ:
VCEL
)
41.02
+0.51 (+1.26%)
Delayed Quote
Updated: 3:35 PM EST, Nov 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vericel Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
August 28, 2025
From
Vericel Corporation
Via
GlobeNewswire
MediWound Revenue Jumps 43% in Q2
↗
August 14, 2025
Via
The Motley Fool
Vericel Corp (NASDAQ:VCEL): A High-Growth Stock with a Promising Technical Setup
↗
August 14, 2025
Vericel Corp (VCEL) is a high-growth biotech stock with strong fundamentals and a promising technical setup, making it a potential breakout candidate for investors.
Via
Chartmill
Vericel Q2 Revenue Jumps 20%
↗
August 05, 2025
Via
The Motley Fool
Topics
Intellectual Property
Earnings Scheduled For July 31, 2025
↗
July 31, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
Where Vericel Stands With Analysts
↗
February 28, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
What 7 Analyst Ratings Have To Say About Vericel
↗
February 03, 2025
Via
Benzinga
Vericel Corp (NASDAQ: VCEL) Posts Mixed Q2 2025 Results with Revenue Miss and EPS Beat
↗
July 31, 2025
Vericel Corp (VCEL) posted mixed Q2 2025 results with revenue missing estimates but EPS beating expectations. Shares fell 6.5% pre-market despite strong MACI growth and margin expansion.
Via
Chartmill
Vericel Reports Second Quarter 2025 Financial Results
July 31, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
July 17, 2025
From
Vericel Corporation
Via
GlobeNewswire
VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with Technical Breakout Potential
↗
July 02, 2025
VERICEL CORP (NASDAQ:VCEL) shows strong growth fundamentals and a technical breakout pattern, making it a stock to watch in the biotech sector.
Via
Chartmill
Beyond The Numbers: 5 Analysts Discuss Vericel Stock
↗
January 15, 2025
Via
Benzinga
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
June 10, 2025
From
Vericel Corporation
Via
GlobeNewswire
VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with Technical Breakout Potential
↗
June 06, 2025
VERICEL CORP (NASDAQ:VCEL) shows strong revenue and earnings growth, backed by a solid balance sheet and a promising technical breakout pattern.
Via
Chartmill
What Analysts Are Saying About Vericel Stock
↗
May 22, 2025
Via
Benzinga
VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with a Technical Setup
↗
May 16, 2025
VERICEL CORP (NASDAQ:VCEL) shows strong growth potential with solid profitability and a promising technical setup, making it a stock worth watching.
Via
Chartmill
Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
May 08, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
May 07, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
April 24, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at Multiple Upcoming Investor Conferences
March 04, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
February 27, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
February 13, 2025
From
Vericel Corporation
Via
GlobeNewswire
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
January 15, 2025
Via
Benzinga
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
January 14, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
January 08, 2025
From
Vericel Corporation
Via
GlobeNewswire
Vericel Stock Sees RS Rating Shoot Higher
↗
November 11, 2024
The Relative Strength (RS) Rating for Vericel stock entered a higher percentile Monday, as it got a lift from 69 to 79.
Via
Investor's Business Daily
Smaller Cap Biotechs Are In Season: How Are We Doing?
↗
November 07, 2024
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.
Via
Talk Markets
Vericel Reports Third Quarter 2024 Financial Results
November 07, 2024
From
Vericel Corporation
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
